Vardarli_2011_J.Clin.Endocrinol.Metab_96_945

Reference

Title : Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes - Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
Author(s) : Vardarli I , Nauck MA , Kothe LD , Deacon CF , Holst JJ , Schweizer A , Foley JE
Ref : J Clinical Endocrinology Metab , 96 :945 , 2011
Abstract : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
ESTHER : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
PubMedSearch : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945
PubMedID: 21239518

Related information

Citations formats

Vardarli I, Nauck MA, Kothe LD, Deacon CF, Holst JJ, Schweizer A, Foley JE (2011)
Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes
J Clinical Endocrinology Metab 96 :945

Vardarli I, Nauck MA, Kothe LD, Deacon CF, Holst JJ, Schweizer A, Foley JE (2011)
J Clinical Endocrinology Metab 96 :945